Healthcare & Life Sciences
ArgenX
Netherlandswww.argenx.com
ArgenX is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series C+, 3 tracked investors.
activeseries-c-plus
series-c-plus
Stage
3
Investors
About ArgenX
Based in the Netherlands, ArgenX is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
ArgenX is a global immunology company focused on developing antibody therapies for severe autoimmune diseases, with a primary product, VYVGART, approved for treating generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.
Explore ArgenX's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.